Story thread · 4 reports / 2 sources
Raymond James cuts Dyne Therapeutics price target on DM1 trial risk
investing.com · 6d
First report: C.H. Robinson Shares Rise 1.5% Premarket Without New Company Announcement — finance.yahoo.com, 7d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.